Literature DB >> 14642436

The human frizzled-3 (FZD3) gene on chromosome 8p21, a receptor gene for Wnt ligands, is associated with the susceptibility to schizophrenia.

Takeshi Katsu1, Hiroshi Ujike, Takamitsu Nakano, Yuji Tanaka, Akira Nomura, Kenji Nakata, Manabu Takaki, Ayumu Sakai, Naohiko Uchida, Takaki Imamura, Shigetoshi Kuroda.   

Abstract

Neurodevelopmental abnormalities have been reported in studies on the pathogenesis of schizophrenia. The Wnt-signaling pathway has been implicated in a variety of processes in neurodevelopment, and the frizzled proteins have been identified as receptors for Wnt ligands. Of the frizzled proteins, frizzled-3 (FZD3) is required for formation of the neural crest and for development of major fiber tracts in the CNS. The human FZD3 gene is located on chromosome 8p21, a positive linkage locus for schizophrenia. We analyzed polymorphisms of the FZD3 gene in patients with schizophrenia and control subjects in the Japanese population. We found a significant association between schizophrenia and the FZD3 gene in single nucleotide polymorphisms and haplotype analyses. Our data suggest that dysregulation of the Wnt-signaling pathway may be involved in the susceptibility to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642436     DOI: 10.1016/j.neulet.2003.09.017

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  26 in total

Review 1.  Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.

Authors:  Richard S Jope; Myoung-Sun Roh
Journal:  Curr Drug Targets       Date:  2006-11       Impact factor: 3.465

Review 2.  Wnt signaling: role in Alzheimer disease and schizophrenia.

Authors:  Nibaldo C Inestrosa; Carla Montecinos-Oliva; Marco Fuenzalida
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

3.  Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia.

Authors:  Hugh M D Gurling; Hugo Critchley; Susmita R Datta; Andrew McQuillin; Ekaterina Blaveri; Srinivasa Thirumalai; Jonathan Pimm; Robert Krasucki; Gursharan Kalsi; Digby Quested; Jacob Lawrence; Nicholas Bass; Khalid Choudhury; Vinay Puri; Owen O'Daly; David Curtis; Douglas Blackwood; Walter Muir; Anil K Malhotra; Robert W Buchanan; Catriona D Good; Richard S J Frackowiak; Raymond J Dolan
Journal:  Arch Gen Psychiatry       Date:  2006-08

4.  Wnt2 expression and signaling is increased by different classes of antidepressant treatments.

Authors:  Hideki Okamoto; Bhavya Voleti; Mounira Banasr; Maysa Sarhan; Vanja Duric; Matthew J Girgenti; Ralph J Dileone; Samuel S Newton; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2010-06-08       Impact factor: 13.382

5.  A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen.

Authors:  Xing Chen; Feng Long; Bin Cai; Xiaohong Chen; Lizeng Qin; Gang Chen
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

6.  No association between polymorphisms of WNT2 and schizophrenia in a Korean population.

Authors:  Hak-Jae Kim; Jin Kyung Park; Su Kang Kim; Sung Wook Kang; Jong Woo Kim; Hyun-Kyung Park; Ah-Rang Cho; Ji Young Song; Joo-Ho Chung
Journal:  BMC Med Genet       Date:  2010-05-24       Impact factor: 2.103

7.  Targeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro.

Authors:  Theodore A Slotkin; Frederic J Seidler; Fabio Fumagalli
Journal:  Brain Res Bull       Date:  2008-02-01       Impact factor: 4.077

8.  Association study of Wnt signaling pathway genes in bipolar disorder.

Authors:  Peter P Zandi; Pamela L Belmonte; Virginia L Willour; Fernando S Goes; Judith A Badner; Sylvia G Simpson; Elliot S Gershon; Francis J McMahon; J Raymond DePaulo; James B Potash
Journal:  Arch Gen Psychiatry       Date:  2008-07

Review 9.  Unexplored therapeutic opportunities in the human genome.

Authors:  Tudor I Oprea; Cristian G Bologa; Søren Brunak; Allen Campbell; Gregory N Gan; Anna Gaulton; Shawn M Gomez; Rajarshi Guha; Anne Hersey; Jayme Holmes; Ajit Jadhav; Lars Juhl Jensen; Gary L Johnson; Anneli Karlson; Andrew R Leach; Avi Ma'ayan; Anna Malovannaya; Subramani Mani; Stephen L Mathias; Michael T McManus; Terrence F Meehan; Christian von Mering; Daniel Muthas; Dac-Trung Nguyen; John P Overington; George Papadatos; Jun Qin; Christian Reich; Bryan L Roth; Stephan C Schürer; Anton Simeonov; Larry A Sklar; Noel Southall; Susumu Tomita; Ilinca Tudose; Oleg Ursu; Dušica Vidovic; Anna Waller; David Westergaard; Jeremy J Yang; Gergely Zahoránszky-Köhalmi
Journal:  Nat Rev Drug Discov       Date:  2018-03-23       Impact factor: 84.694

10.  Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease.

Authors:  Giancarlo V De Ferrari; Andreas Papassotiropoulos; Travis Biechele; Fabienne Wavrant De-Vrieze; Miguel E Avila; Michael B Major; Amanda Myers; Katia Sáez; Juan P Henríquez; Alice Zhao; M Axel Wollmer; Roger M Nitsch; Christoph Hock; Chris M Morris; John Hardy; Randall T Moon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.